Fig. 4From: Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular CarcinomaSurvival analysis of ZBTB9 in different clinical subtypes, and pharmacologic response. Kaplan–Meier curve analysis was used to investigate the relationship between ZBTB9 expression and clinical variables (*p < 0.05; **p < 0.01; ***p < 0.001)Back to article page